NIH-funded research NIH-funded research

Understanding the genetic factors of opioid use disorder in the brain

Official title: Deciphering the single-nucleus genomic regulatory structure of opioid use disorder in the human brain

Funded at Yale University · NIH-11106026 · Data updated 2026-11-12

This study is looking at how our genes and their changes in brain cells might affect opioid use disorder, with the goal of finding better ways to help people struggling with addiction.

More Opioid Use research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startJuly 1, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$502,500
NIH project number5DP1DA058737-03
Project IDNIH-11106026 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of opioid use disorder or those at risk due to genetic factors.

Less likely to help

Patients who do not have a history of opioid use disorder or related genetic predispositions may not benefit from this research.

What this research studies

This research investigates the genetic and epigenetic factors contributing to opioid use disorder (OUD) by analyzing single human brain cells. It aims to profile various DNA modifications and the 3D structure of the genome to uncover how these factors influence gene regulation related to OUD. By focusing on individual cell types and brain regions, the study seeks to provide a clearer picture of the biological mechanisms underlying addiction. This approach could lead to more targeted interventions and treatments for those affected by OUD.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for individuals suffering from opioid use disorder.

How similar studies have gone: Previous research has shown promise in understanding genetic factors in addiction, but this specific approach of analyzing single nuclei is relatively novel.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Montalvo-Ortiz, Janitza Liz — Yale University
  • Study coordinator: Montalvo-Ortiz, Janitza Liz

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.